Da Pan , Yuanyuan Wang , Chen Zhang , Yifei Lu , Shiyu Yin , Pei Wang , Jiayue Xia , Junhui Yu , Han Gao , Guiju Sun , Dengfeng Xu
{"title":"昼夜节律因素能改善死亡风险预测吗?代谢和昼夜综合征的双队列分析。","authors":"Da Pan , Yuanyuan Wang , Chen Zhang , Yifei Lu , Shiyu Yin , Pei Wang , Jiayue Xia , Junhui Yu , Han Gao , Guiju Sun , Dengfeng Xu","doi":"10.1016/j.diabres.2025.112919","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><div>This study prospectively evaluated the associations between metabolic syndrome (MetS), circadian syndrome (CircS) and mortality from major diseases.</div></div><div><h3>Methods</h3><div>We conducted prospective analyses using data from two large cohorts: NHANES (n = 14,727 for MetS; 13,799 for CircS, aged ≥ 20 years) and the UK Biobank (n = 404,028 for MetS; 376,236 for CircS, aged ≥ 40 years). We assessed associations between MetS, CircS, and all-cause, cardiovascular, and cancer mortality, using Cox proportional hazards models. Model performance was compared using C-index, Brier Score, AIC, and BIC.</div></div><div><h3>Results</h3><div>In NHANES, the prevalences of MetS and CircS were 41.1 % and 31.7 %, respectively, while in UKB, they were 29.9 % and 17.6 %, respectively. In fully adjusted models, MetS was significantly associated with a 21 % increase in all-cause mortality, and CircS was significantly associated with a 34 % increase in all-cause mortality and a 65 % increase in heart diseases mortality in the NHANES cohort; both MetS and CircS were significantly associated with increased risks of mortality from heart diseases (MetS: HR = 1.68; 95 % CI, 1.58–1.79; CircS: HR = 1.78; 95 % CI, 1.66–1.90), cancers (MetS: HR = 1.19; 95 % CI, 1.15–1.24; CircS: HR = 1.24; 95 % CI, 1.19–1.29), CVD (MetS: HR = 1.56; 95 % CI, 1.48–1.64; CircS: HR = 1.66; 95 % CI, 1.56–1.75), ischemic heart disease (MetS: HR = 1.81; 95 % CI, 1.68–1.96; CircS: HR = 1.93; 95 % CI, 1.79–2.09), stroke (MetS: HR = 1.36; 95 % CI, 1.21–1.53; CircS: HR = 1.42; 95 % CI, 1.24–1.61), and all-cause mortality (MetS: HR = 1.30; 95 % CI, 1.26–1.33; CircS: HR = 1.42; 95 % CI, 1.38–1.46) in the UKB cohort. CircS showed stronger associations with all mortality outcomes across both cohorts. Subgroup analyses revealed stronger associations in middle-aged adults, but weaker associations in those ≥ 70 years. CircS-based models consistently outperformed MetS-based models in terms of AIC and BIC.</div></div><div><h3>Conclusions</h3><div>CircS may provide a more comprehensive and interpretable framework for mortality risk prediction than MetS. Its potential incorporation into clinical and public health practice warrants further investigation.</div></div>","PeriodicalId":11249,"journal":{"name":"Diabetes research and clinical practice","volume":"229 ","pages":"Article 112919"},"PeriodicalIF":7.4000,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Do circadian factors improve mortality risk prediction? A dual-cohort analysis of metabolic and circadian syndromes\",\"authors\":\"Da Pan , Yuanyuan Wang , Chen Zhang , Yifei Lu , Shiyu Yin , Pei Wang , Jiayue Xia , Junhui Yu , Han Gao , Guiju Sun , Dengfeng Xu\",\"doi\":\"10.1016/j.diabres.2025.112919\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Aims</h3><div>This study prospectively evaluated the associations between metabolic syndrome (MetS), circadian syndrome (CircS) and mortality from major diseases.</div></div><div><h3>Methods</h3><div>We conducted prospective analyses using data from two large cohorts: NHANES (n = 14,727 for MetS; 13,799 for CircS, aged ≥ 20 years) and the UK Biobank (n = 404,028 for MetS; 376,236 for CircS, aged ≥ 40 years). We assessed associations between MetS, CircS, and all-cause, cardiovascular, and cancer mortality, using Cox proportional hazards models. Model performance was compared using C-index, Brier Score, AIC, and BIC.</div></div><div><h3>Results</h3><div>In NHANES, the prevalences of MetS and CircS were 41.1 % and 31.7 %, respectively, while in UKB, they were 29.9 % and 17.6 %, respectively. In fully adjusted models, MetS was significantly associated with a 21 % increase in all-cause mortality, and CircS was significantly associated with a 34 % increase in all-cause mortality and a 65 % increase in heart diseases mortality in the NHANES cohort; both MetS and CircS were significantly associated with increased risks of mortality from heart diseases (MetS: HR = 1.68; 95 % CI, 1.58–1.79; CircS: HR = 1.78; 95 % CI, 1.66–1.90), cancers (MetS: HR = 1.19; 95 % CI, 1.15–1.24; CircS: HR = 1.24; 95 % CI, 1.19–1.29), CVD (MetS: HR = 1.56; 95 % CI, 1.48–1.64; CircS: HR = 1.66; 95 % CI, 1.56–1.75), ischemic heart disease (MetS: HR = 1.81; 95 % CI, 1.68–1.96; CircS: HR = 1.93; 95 % CI, 1.79–2.09), stroke (MetS: HR = 1.36; 95 % CI, 1.21–1.53; CircS: HR = 1.42; 95 % CI, 1.24–1.61), and all-cause mortality (MetS: HR = 1.30; 95 % CI, 1.26–1.33; CircS: HR = 1.42; 95 % CI, 1.38–1.46) in the UKB cohort. CircS showed stronger associations with all mortality outcomes across both cohorts. Subgroup analyses revealed stronger associations in middle-aged adults, but weaker associations in those ≥ 70 years. CircS-based models consistently outperformed MetS-based models in terms of AIC and BIC.</div></div><div><h3>Conclusions</h3><div>CircS may provide a more comprehensive and interpretable framework for mortality risk prediction than MetS. Its potential incorporation into clinical and public health practice warrants further investigation.</div></div>\",\"PeriodicalId\":11249,\"journal\":{\"name\":\"Diabetes research and clinical practice\",\"volume\":\"229 \",\"pages\":\"Article 112919\"},\"PeriodicalIF\":7.4000,\"publicationDate\":\"2025-09-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes research and clinical practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0168822725009337\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes research and clinical practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168822725009337","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
Do circadian factors improve mortality risk prediction? A dual-cohort analysis of metabolic and circadian syndromes
Aims
This study prospectively evaluated the associations between metabolic syndrome (MetS), circadian syndrome (CircS) and mortality from major diseases.
Methods
We conducted prospective analyses using data from two large cohorts: NHANES (n = 14,727 for MetS; 13,799 for CircS, aged ≥ 20 years) and the UK Biobank (n = 404,028 for MetS; 376,236 for CircS, aged ≥ 40 years). We assessed associations between MetS, CircS, and all-cause, cardiovascular, and cancer mortality, using Cox proportional hazards models. Model performance was compared using C-index, Brier Score, AIC, and BIC.
Results
In NHANES, the prevalences of MetS and CircS were 41.1 % and 31.7 %, respectively, while in UKB, they were 29.9 % and 17.6 %, respectively. In fully adjusted models, MetS was significantly associated with a 21 % increase in all-cause mortality, and CircS was significantly associated with a 34 % increase in all-cause mortality and a 65 % increase in heart diseases mortality in the NHANES cohort; both MetS and CircS were significantly associated with increased risks of mortality from heart diseases (MetS: HR = 1.68; 95 % CI, 1.58–1.79; CircS: HR = 1.78; 95 % CI, 1.66–1.90), cancers (MetS: HR = 1.19; 95 % CI, 1.15–1.24; CircS: HR = 1.24; 95 % CI, 1.19–1.29), CVD (MetS: HR = 1.56; 95 % CI, 1.48–1.64; CircS: HR = 1.66; 95 % CI, 1.56–1.75), ischemic heart disease (MetS: HR = 1.81; 95 % CI, 1.68–1.96; CircS: HR = 1.93; 95 % CI, 1.79–2.09), stroke (MetS: HR = 1.36; 95 % CI, 1.21–1.53; CircS: HR = 1.42; 95 % CI, 1.24–1.61), and all-cause mortality (MetS: HR = 1.30; 95 % CI, 1.26–1.33; CircS: HR = 1.42; 95 % CI, 1.38–1.46) in the UKB cohort. CircS showed stronger associations with all mortality outcomes across both cohorts. Subgroup analyses revealed stronger associations in middle-aged adults, but weaker associations in those ≥ 70 years. CircS-based models consistently outperformed MetS-based models in terms of AIC and BIC.
Conclusions
CircS may provide a more comprehensive and interpretable framework for mortality risk prediction than MetS. Its potential incorporation into clinical and public health practice warrants further investigation.
期刊介绍:
Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas. The role of the journal is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and patient care. Topics of focus include translational science, genetics, immunology, nutrition, psychosocial research, epidemiology, prevention, socio-economic research, complications, new treatments, technologies and therapy.